• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    SciSparc Ltd. - Ordinary Shares (NQ: SPRC )

    1.250 -0.010 (-0.80%)
    Streaming Delayed Price Updated: 1:16 PM EDT, May 3, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 24,286
    Open 1.320
    Bid (Size) 1.240 (1)
    Ask (Size) 1.250 (4)
    Prev. Close 1.260
    Today's Range 1.240 - 1.335
    52wk Range 1.150 - 17.94
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates. 
    Via Benzinga
    Why Macatawa Bank Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
    Shares of Macatawa Bank Corporation (NASDAQ: MCBC) rose sharply in today’s pre-market trading after Wintrust Financial Corporation (NASDAQ: WFTC) and Macatawa Bank announced that they have entered into... 
    Via Benzinga

    Performance

    YTD
    -75.44%
    -75.44%
    1 Month
    -30.56%
    -30.56%
    3 Month
    -65.47%
    -65.47%
    6 Month
    -78.15%
    -78.15%
    1 Year
    -92.55%
    -92.55%

    More News

    Read More
    Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    SciSparc To Acquire AutoMax, A Strategic Leap Towards Industry Diversification
    Via Benzinga
    SciSparc to Acquire AutoMax
    From SciSparc Ltd
    Via GlobeNewswire
    Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression
    From SciSparc Ltd
    Via GlobeNewswire
    SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research
    From SciSparc Ltd
    Via GlobeNewswire
    SciSparc Granted Another Patent, Strengthening its Core Technology in Canada
    From SciSparc Ltd
    Via GlobeNewswire
    SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial
    From SciSparc Ltd
    Via GlobeNewswire
    Podcast: Clearmind's Non-Hallucinogenic Psychoactive Molecule Could Become A Solution For Addictive Behaviors
    Via Benzinga
    SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure
    From SciSparc Ltd
    Via GlobeNewswire
    Autism CBD Trial Enrolls Children: This Israeli Co. Is Making Headway In New Treatments
    Via Benzinga
    Topics Intellectual Property
    Exposures Intellectual Property
    SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder
    From SciSparc Ltd
    Via GlobeNewswire
    SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe
    From SciSparc Ltd
    Via GlobeNewswire
    SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology
    From SciSparc Ltd
    Via GlobeNewswire
    Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
    Via Benzinga
    SciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dosing
    From SciSparc Ltd
    Via GlobeNewswire
    SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine Compounds
    From SciSparc Ltd
    Via GlobeNewswire
    Clearmind Medicine Submits Three Additional International Patent Applications for Innovative MDMA, Ibogaine and Ketamine Compounds
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    EXCLUSIVE: Psychedelic-Focused Firm Clearmind Medicine Submits Three New International Patent Applications For MDMA, Ibogaine And Ketamine Compounds
    Via Benzinga
    Topics Intellectual Property
    Exposures Intellectual Property
    Next-Gen Psychedelics Companies SciSparc And Clearmind Collaboration File 3 Patents
    Via Benzinga
    Topics Intellectual Property
    Exposures Intellectual Property
    What's Going On With Psychedelic Drug-Developers SciSparc And Clearmind Stock?
    Via Benzinga
    Topics Intellectual Property
    Exposures Intellectual Property
    Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Clearmind Medicine Submits Three International Patent Applications for Next Generation Classic Psychedelic-Based Compounds
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.